Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from across the Medical Sciences Division are working hard to combat the COVID-19 crises. With particular strengths in infectious diseases and international health, we are well placed to contribute to better understanding and effectively controlling the epidemic. We have a long history of responding to crises, in the UK and around the world and are leaders in emergency vaccine development. During the 2014 Ebola outbreak, our scientists performed the world’s first human Ebola vaccine studies, starting them before any other university or company. Our researchers, in collaboration with partners across the globe, are working to develop an effective vaccine and drugs to target this virus, and have already introduced innovative public health measures and collaborative online tools that are being used in hospitals here and abroad.

Coronavirus-related news from across the Medical Sciences Division

New AI test identifies COVID-19 within one hour in emergency departments

Infectious disease and clinical machine learning experts at the University of Oxford have developed an Artificial Intelligence test that can rapidly screen for COVID-19 in patients arriving in emergency departments, and a preprint paper has been published on its effectiveness.

New Programme Helps Frontline Healthcare Workers at Risk from PTSD and Depression

Researchers from the Department of Experimental Psychology at the University of Oxford have developed a new mental health treatment programme to provide frontline healthcare workers with 1-to-1 support, including fast-track access to PTSD or depression treatment. This evidence-based programme, called SHAPE Recovery, builds on an outreach programme shown to reduce rates of PTSD and depression.

Why we can’t tell if warmer weather slows down the spread of coronavirus

Many people believe that warm weather protects us from respiratory illnesses such as COVID-19. The concept of "catching a cold" in summer is counter-intuitive. Yet what does the data say about the effect of the weather on the spread of the coronavirus?

Running, cycling and singing against COVID-19

People around the country are doing some incredible things to support Oxford’s time-critical coronavirus research, from running multiple marathons to embarking on epic cycle rides, and even releasing music.

New evidence against one proposed mechanism of hypoxia in COVID-19

DPAG is among the departments receiving funding from the University's research respond fund to undertake COVID-19 research. As part of this effort, the Swietach lab has been studying oxygen transport in the blood of COVID-19 patients.

New treatment reduces COVID-19 patients needing intensive care

The preliminary results of a clinical trial supported by NIHR Oxford BRC researchers have suggested that a new treatment for COVID-19 dramatically reduces the number of patients needing intensive care.

Oxford immunologist on coronavirus vaccine: our early results look highly promising

A vaccine against COVID-19 is urgently needed if we’re to stop the virus spreading and prevent potentially millions of further deaths. We’re now one step closer to that goal.

New study reveals Oxford coronavirus vaccine produces strong immune response

A team of scientists at Oxford University’s Jenner Institute and Oxford Vaccine Group has taken the next step towards the discovery of a safe, effective and accessible vaccine against coronavirus.

Oxford study suggests notable decline in coronavirus cases and R rate on Isle of Wight after launch of the test and trace programme

A team of epidemiologists, mathematical modellers and economists at Oxford University has released an independent analysis of the trends in the number of coronavirus infections (incidence) on the Isle of Wight, UK before and during the first phase of the test and trace programme (TT), including the first version of the NHS contact tracing app. Results of the study, which has not yet been subject to formal peer review, can be explored on EpiNow interactive tool.

Agile start-ups partner with academics to find COVID-19 solutions

Three companies at Oxford’s BioEscalator are developing new detection methods and have discovered potential therapeutics in the fight against COVID-19.